1
2
Stevanovic, J., de Jong, L. A., Kappelhoff, B. S., Dvortsin, E. P., Voorhaar, M., Postma, M. J.
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
3
4
Kamphuisen, P. W., Oudkerk, M.
Veröffentlicht in: Kamphuisen , P W & Oudkerk , M 2007 , ' Diagnosis of deep-vein thrombosis and pulmonary embolism : The new guideline of the Dutch institute for health care improvement ' , Imaging Decisions MRI , vol. 11 , no. 3 , pp. 3-7 . https://doi.org/10.1111/j.1617-0830.2007.00093.x;
2007
Veröffentlicht in: Kamphuisen , P W & Oudkerk , M 2007 , ' Diagnosis of deep-vein thrombosis and pulmonary embolism : The new guideline of the Dutch institute for health care improvement ' , Imaging Decisions MRI , vol. 11 , no. 3 , pp. 3-7 . https://doi.org/10.1111/j.1617-0830.2007.00093.x;
2007
5
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
6
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
7